Table 5.
Medications at baseline and 1-year follow-up [n (%)]
| Medications | Baseline (n = 131) | 1-year follow-up (n = 126) | P-value |
|---|---|---|---|
| Antiplatelet therapy | 35 (26.7) | 85 (67.5) | < 0.001 |
| β-blocker | 28 (21.4) | 68 (54.0) | < 0.001 |
| Calcium channel blockers | 35 (26.7) | 28 (22.2) | 0.312 |
| ACE-I/ARB | 35 (26.7) | 56 (44.4) | 0.003 |
| Diuretics | 10 (7.6) | 10 (7.9) | 1 |
| Statins | 28 (21.4) | 86 (68.3) | < 0.001 |
| Hypoglycemic agents | 22 (16.8) | 29 (23.0) | 0.215 |
ACE-I/ARB angiotensin-converting enzyme inhibitors / angiotensin II receptor blockers